ADVENTRX PHARMACEUTICALS INC (ANX) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 57 transactions totaling $268.7K, demonstrating a bullish sentiment with $76.8K in net insider flow. The most recent transaction on Dec 13, 2012 involved a transaction of 305,608 shares valued at $0.
No significant insider buying has been recorded for ANX in the recent period.
No significant insider selling has been recorded for ANX in the recent period.
Based on recent SEC filings, insider sentiment for ANX is bullish with an Insider Alignment Score of 64/100 and a net flow of $76.8K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at ADVENTRX PHARMACEUTICALS INC (ANX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading ANX stock, having executed 57 transactions in the past 90 days. The most active insider is M. Ross Johnson (Executive), who has made 2 transactions totaling $492.5K.
Get notified when executives and directors at ANX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 13, 2012 | Martin Emanuele Robert | Executive | Other | 305,608 | $N/A | $0 | |
| May 14, 2012 | A. Ramsay David | Executive | Purchase | 50,000 | $0.54 | $27.0K | |
| May 10, 2012 | A. Ramsay David | Executive | Purchase | 40,000 | $0.57 | $22.8K | |
| May 9, 2012 | A. Ramsay David | Executive | Purchase | 10,000 | $0.55 | $5.5K | |
| Mar 14, 2012 | M. Culley Brian | Executive | Purchase | 20,500 | $0.59 | $12.1K | |
| Mar 13, 2012 | M. Culley Brian | Executive | Purchase | 14,000 | $0.58 | $8.1K | |
| Dec 16, 2011 | Martin Emanuele Robert | Executive | Sale | 41,000 | $0.60 | $24.6K | |
| May 27, 2010 | M. Culley Brian | Executive | Purchase | 5,000 | $1.89 | $9.4K | |
| May 14, 2008 | M. Robbins Joan | Executive | Purchase | 5,000 | $0.43 | $2.1K | |
| May 13, 2008 | M. Robbins Joan | Executive | Purchase | 5,000 | $0.44 | $2.2K | |
| Feb 8, 2008 | Levine Evan | Executive | Purchase | 2,000 | $0.50 | $1.0K | |
| Feb 8, 2008 | Levine Evan | Executive | Purchase | 3,000 | $0.51 | $1.5K | |
| Feb 5, 2008 | Levine Evan | Executive | Purchase | 2,000 | $0.42 | $840 | |
| Feb 5, 2008 | Levine Evan | Executive | Purchase | 3,000 | $0.43 | $1.3K | |
| Feb 4, 2008 | Levine Evan | Executive | Purchase | 5,000 | $0.42 | $2.1K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Exercise (Options)(X) | 7 | $316.5K | 38.1% |
Payment(F) | 1 | $246.2K | 29.6% |
Purchase(P) | 37 | $172.8K | 20.8% |
Sale(S) | 11 | $95.9K | 11.5% |
Other(J) | 1 | $0 | 0.0% |
Insiders at ADVENTRX PHARMACEUTICALS INC are accumulating shares at an accelerated pace. With 9 insiders making 57 transactions totaling $172.8K in purchases versus $95.9K in sales, the net buying activity of $76.8K signals strong executive confidence. M. Ross Johnson (Executive) leads the buying activity with $492.5K in transactions across all time.